| Members |
targetComponentId |
| Homodigital finger flap |
Flap (substance) |
| Hongiella mannitolivorans (organism) |
Algoriphagus mannitolivorans (organism) |
| Hordeolum internum |
orgelet interne |
| Hormone substitute |
traitement hormonal |
| Horse allergy vaccine (substance) |
Horse allergy vaccine |
| Horseradish - dietary (substance) |
Horseradish (substance) |
| Horseradish - dietary |
Horseradish (substance) |
| Hot comb alopecia (disorder) |
Central centrifugal cicatricial alopecia (disorder) |
| Hottentot |
Khoikhoi |
| Hottentot language |
langue Khoisan |
| House dust allergy vaccine (substance) |
House dust allergy vaccine (product) |
| House mite allergy vaccine (substance) |
House mite allergy vaccine (product) |
| Human adenovirus 40 antigen |
Antigen of Human mastadenovirus F (substance) |
| Human adenovirus 41 antigen |
Antigen of Human mastadenovirus F (substance) |
| Human alpha1 proteinase inhibitor 1000mg powder for injection solution vial (product) |
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial |
| Human alpha1 proteinase inhibitor 500mg injection solution vial + diluent (product) |
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
| Human alpha1 proteinase inhibitor 500mg powder for conventional release solution for injection vial (product) |
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
| Human chorionic gonadotropin 10,000iu powder and solvent for injection solution vial (product) |
Product containing precisely human chorionic gonadotropin 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Human coronavirus HK1 (organism) |
Human coronavirus HKU1 |
| Human herpesvirus 1 group virus |
Genus Simplexvirus (organism) |
| Human herpesvirus 3 group virus |
Genus Varicellovirus (organism) |
| Human immunodeficiency virus (HIV) II infection category B1 (disorder) |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
| Human immunodeficiency virus (HIV) infection category B1 |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
| Human immunodeficiency virus type 2 |
virus de l'immunodéficience humaine de type 2 |
| Human immunodeficiency virus type I |
Human immunodeficiency virus type I |
| Human immunodeficiency virus, type II glycoprotein 53 antibody |
Human immunodeficiency virus 2 protein 53 antibody (substance) |
| parodontite associée au virus de l'immunodéficience humaine |
Periodontitis exacerbated by human immunodeficiency virus infection (disorder) |
| Human immunoglobulin IgG 200mg/mL solution for injection (product) |
Product containing only human immunoglobulin G (medicinal product) |
| Human insulin 1mg unit dose blister dry powder for inhalation (product) |
Human insulin-containing product |
| Human insulin 3mg unit dose blister dry powder for inhalation (product) |
Human insulin-containing product |
| Human interferon gamma-1b 200 micrograms/mL injection solution 0.5mL vial (product) |
Interferon gamma-1b 200 microgram/mL solution for injection |
| Human interferon gamma-1b adverse reaction |
Adverse reaction to interferon gamma-1b |
| Human leukocyte antigen A 3101 present (finding) |
Human leukocyte antigen A*31:01 positive (finding) |
| Human leukocyte antigen B 1502 present (finding) |
Human leukocyte antigen B*15:02 positive (finding) |
| Human leukocyte antigen B 5701 present (finding) |
HLA-B*57:01 positive |
| Human menopausal gonadotrophins 150iu injection (product) |
Human menopausal gonadotropin only product |
| Human menopausal gonadotrophins 150iu injection (product) |
Human menopausal gonadotropin only product |
| Human menopausal gonadotrophins 150units(FSH) injection (pdr for recon)+solvent (product) |
Human menopausal gonadotropin only product |
| Human menopausal gonadotrophins 75iu injection (product) |
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
| Human menopausal gonadotrophins 75iu injection (product) |
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
| Human menopausal gonadotrophins 75units(FSH) powder and solvent for injection solution vial (product) |
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
| Human normal immunoglobulin 10g i-v infusion (pdr for recon) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 10g i-v infusion (pdr for recon)+diluent (product) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 10g infusion solution vial (product) |
Product containing precisely human immunoglobulin G 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Human normal immunoglobulin 12g infusion solution vial (product) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 16% injection solution vial (product) |
Product containing precisely human immunoglobulin G 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Human normal immunoglobulin 1g infusion solution vial (product) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 2.5g i-v infusion (pdr for recon) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 2.5g i-v infusion (pdr for recon)+diluent (product) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 2.5g infusion solution vial (product) |
Product containing precisely human immunoglobulin G 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Human normal immunoglobulin 250mg injection solution vial (product) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 3g infusion solution vial (product) |
Product containing precisely human immunoglobulin G 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Human normal immunoglobulin 500mg i-v infusion (pdr for recon) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 500mg i-v infusion (pdr for recon)+diluent (product) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 500mg infusion solution vial (product) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 5g i-v infusion (pdr for recon) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 5g i-v infusion (pdr for recon)+diluent (product) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human normal immunoglobulin 5g infusion solution vial (product) |
Product containing precisely human immunoglobulin G 5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Human normal immunoglobulin 6g conventional release solution for injection vial (product) |
Human immunoglobulin G 6 G powder for solution for injection vial |
| Human normal immunoglobulin 6g infusion solution vial (product) |
Human immunoglobulin G 6 G powder for solution for injection vial |
| Human normal immunoglobulin 750mg injection solution vial (product) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
| Human papilloma virus type 9 vaccine (substance) |
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
| Human papillomavirus group (organism) |
papillomavirus humain |
| Human protein C 1000iu injection (pdr for recon)+solvent (product) |
Product containing precisely human protein C 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Human protein C 1000iu injection powder for reconstitution+solvent (product) |
Product containing precisely human protein C 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Human protein C 500iu injection (pdr for recon)+solvent (product) |
Product containing precisely human protein C 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Human protein C 500iu injection powder for reconstitution+solvent (product) |
Product containing precisely human protein C 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Human recombinant choriogonadotropin alfa 250micrograms injection powder for reconstitution + solvent (product) |
Choriogonadotropin alfa only product in parenteral dose form |
| Human tick-borne encephalitis immunoglobulin injection solution 1 mL vial (product) |
Human tick borne encephalitis immunoglobulin only product in parenteral dose form |
| Human tick-borne encephalitis immunoglobulin injection solution 10 mL vial (product) |
Human tick borne encephalitis immunoglobulin only product in parenteral dose form |
| Human tick-borne encephalitis immunoglobulin injection solution 2 mL vial (product) |
Human tick borne encephalitis immunoglobulin only product in parenteral dose form |
| Human tick-borne encephalitis immunoglobulin injection solution 5 mL vial (product) |
Human tick borne encephalitis immunoglobulin only product in parenteral dose form |
| Human vaccination |
administration d'un vaccin pour produire une immunité active (intervention) |
| Human vaccinia immune globulin 50mg/mL injection solution 50mL vial (product) |
Vaccinia human immune globulin 50 mg/mL solution for injection |
| Humulin insulin adverse reaction |
Adverse reaction caused by human insulin (disorder) |
| Hyaline membrane disease (disorder) |
syndrome de détresse respiratoire du nouveau-né (trouble) |
| Hyaluronidase 1500unt/10mL injection (product) |
Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Hyaluronidase 150unt/mL injection solution 10mL vial (product) |
Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Hyaluronidase 150unt/mL injection solution 1mL vial (product) |
Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Hydatidiform mole, no International Classification of Diseases for Oncology subtype (morphologic abnormality) |
Hydatidiform mole, benign (morphologic abnormality) |
| Hydrazide antituberculosis agent (substance) |
Antituberculosis agent |
| Hydrazide antituberculosis drug adverse reaction |
Isoniazid adverse reaction |
| Hydrochlorothiazide + quinapril hydrochloride (product) |
Product containing hydrochlorothiazide and quinapril (medicinal product) |
| Hydrochlorothiazide + quinapril hydrochloride 12.5mg/10mg tablet (product) |
Hydrochlorothiazide 12.5 mg and quinapril (as quinapril hydrochloride) 10 mg oral tablet |
| Hydrochlorothiazide 25mg (product) |
Hydrochlorothiazide 25 mg oral tablet |
| Hydrocortisone 1% + Pramocaine 1% conventional release rectal foam |
Hydrocortisone and pramoxine only product |
| Hydrocortisone 1% + Pramocaine 1% foam enema (product) |
Hydrocortisone and pramoxine only product |
| Hydrocortisone 100mg powder and solvent for injection solution vial (product) |
Hydrocortisone (as hydrocortisone sodium succinate) 100 mg powder for solution for injection vial |
| Hydrocortisone 100mg/60mL (product) |
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) |
| Hydrocortisone 100mg/60mL enema (product) |
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) |
| Hydrocortisone 2% topical lotion (product) |
Hydrocortisone acetate 20 mg/mL cutaneous lotion |
| Hydrocortisone acetate 1% eye drops (product) |
Hydrocortisone 10 mg/mL eye solution |
| Hydrocortisone acetate 2.5% cream (product) |
Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
| Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops (product) |
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
| Hydrocortisone cypionate 10mg/5mL suspension (product) |
Product containing precisely hydrocortisone 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Hydrocortisone/neomycin cream (product) |
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream |
| Hydrolyase |
Hydrolyase |
| Hydromorphone hydrochloride 100% powder (product) |
Hydromorphone only product |
| Hydromorphone hydrochloride 12mg m/r capsule (product) |
Product containing only hydromorphone in oral dose form (medicinal product form) |
| Hydromorphone hydrochloride 12mg prolonged-release oral capsule (product) |
Product containing only hydromorphone in oral dose form (medicinal product form) |
| Hydromorphone hydrochloride 1mg/mL injection solution ampule (product) |
Hydromorphone hydrochloride 1 mg/mL solution for injection |
FHIR